| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.28 | 0.08 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |